Blog icon

Dr Warwick Locke

Research Scientist


Dr Locke's research primarily involves epigenetics and genomics, with a particular focus on DNA methylation. Currently, Dr Locke is undertaking research to exploit DNA methylation patterns for the detection and diagnosis of brain injury.

In his previous role, Dr Locke researched the impact of epigenomic dysregulation on the initiation of carcinogenesis (i.e. the formation of cancer). During this time, Dr Locke was also part of a large multi-center team working to develop biomarkers for the diagnosis and prognosis of triple negative breast cancer.

Current Roles

  • Research Scientist
    Diagnostics Development Team Leader

Academic Qualifications

  • 2013

    University of New South Wales

  • 2006

    BSc (Honours)
    The University of New England

  • 2005

    BSc Biochemistry & Genetics (Double Major)
    The University of New England

Professional Experiences

  • April 2013-April 2017

    Postdoctoral Scientist
    The Garvan Institute of Medical Research

Community and Corporate Citizenship

  • 25/07/2022-24/07/2023

    Westmead Deputy Site Leader